Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid Tumors

Clinical trial NCT00777699 · COMPLETED

Trial details

NCT number: NCT00777699
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Non-Small Cell Lung Cancer

Start date: 2008-08-01
Primary completion: 2011-02-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.